Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Keisuke Fujitaka"'
mRNAs in urinary nano‑extracellular vesicles as potential biomarkers for non‑invasive kidney biopsy.
Autor:
KEISUKE FUJITAKA1,2, TAKU MURAKAMI3, MASATO TAKEUCHI4, TETSUHIRO KAKIMOTO1, HIDEKI MOCHIDA1, KENJI ARAKAWA5 arakawa.kenji@mu.mt‑pharma.co.jp
Publikováno v:
Biomedical Reports. Jan2021, Vol. 14 Issue 1, p1-8. 8p.
Autor:
Masamichi Koyanagi, Yoshihiro Yamamoto, Stefanie Dimmeler, Yoshihiro Hata, Daisuke Sato, Andreas M. Zeiher, Miyuki Nakano, Chiharu Enoki, Haengnam Park, Yasushi Adachi, Hiroshi Kishimoto, Keisuke Fujitaka, Kensaku Wada, Naoki Minato, Masayoshi Iwasaki, Keita Horitani, Ichiro Shiojima
Publikováno v:
Circulation Journal. 82:1459-1465
BACKGROUND We previously identified circulating mesoangioblasts (cMABs), a subset of mesenchymal stem cells that express cardiac mesodermal markers, in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). We also found that hepatocy
Autor:
Masato Takeuchi, Keisuke Fujitaka, Hideki Mochida, Taku Murakami, Tetsuhiro Kakimoto, Kenji Arakawa
Publikováno v:
Biomedical Reports
Urinary nano-extracellular vesicles (NVs), including exosomes and microvesicles, are considered potential biomarkers for kidney diseases using liquid biopsies. However, clinical application of urinary NVs has not yet been validated. In the present st
Autor:
Kinya Okada, Hiroyuki Utsumi, Tetsuhiro Kakimoto, Atsushi Fukunari, Keisuke Fujitaka, Masashi Nishio, Tsuyoshi Kato
Publikováno v:
Experimental and Toxicologic Pathology. 67:171-177
Podocytes are an essential component of the renal glomerular filtration barrier, their injury playing an early and important role in progressive renal dysfunction. This makes quantification of podocyte marker immunoreactivity important for early dete
Autor:
Kinya Okada, Hiroyuki Utsumi, Yoshihiro Hirohashi, Mizue Kawai, Keisuke Fujitaka, Tsuyoshi Kato, Raissa Relator, Atsushi Fukunari, Tetsuhiro Kakimoto, Taku Iguchi, Masashi Nishio
Publikováno v:
Journal of Endocrinology. 222:43-51
Diabetic nephropathy is a major complication in diabetes and a leading cause of end-stage renal failure. Glomerular podocytes are functionally and structurally injured early in diabetic nephropathy. A non-obese type 2 diabetes model, the spontaneousl
Autor:
Keisuke Fujitaka, Masayoshi Iwasaki, Dipak K. Das, Emiko Nomura, Fusakazu Jo, Mitsushige Nishikawa, Hajime Otani, Toshiji Iwasaka, Hiromi Jo
Publikováno v:
Nutrition research (New York, N.Y.). 31(11)
Resveratrol is known to improve endothelial function in animals, but little is known about its effect on human subjects. Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors underlying endothelial dysfunction. We hypothesized that th
Autor:
Emiko Nomura, Keisuke Fujitaka, Masayoshi Iwasaki, Mitsushige Nishikawa, Fusakazu Jo, Hajime Otani, Toshiji Iwasaka, Hiromi Jo
Publikováno v:
Endocrine journal. 58(6)
Type 2 diabetes mellitus (T2DM) associated with metabolic syndrome (MetS) represents a high risk of cardiovascular disease. We compared the effect of early intervention with pioglitazone versus voglibose on physical and metabolic profiles and serum a
Autor:
Masato Baden, Tetsuro Sugiura, Kengo Hatada, Yoshiaki Tsuka, Toshiji Iwasaka, Seishi Nakamura, Yusuke Fujikawa, Shigeo Umemura, Keisuke Fujitaka
Publikováno v:
Nuclear medicine communications. 30(10)
Multislice computed tomography (MSCT) coronary angiography (CAG) is limited in detecting significant coronary artery stenosis because of its low specificity and positive predictive value. Stress-rest myocardial perfusion imaging (MPI) can detect myoc
Autor:
Toshiji Iwasaka, Shigeo Umemura, Keisuke Fujitaka, Tetsuro Sugiura, Susumu Yoshida, Yoshiaki Tsuka, Seishi Nakamura, Masato Baden
Publikováno v:
Nuclear medicine communications. 27(3)
OBJECTIVE: Angiographic thrombolysis in myocardial infarction (TIMI) flow grade < or = 2 after primary percutaneous coronary intervention (PCI), defined as angiographic no-reflow, predicts poor functional recovery in patients with acute myocardial in
Autor:
Fujitaka, Keisuke, Nakamura, Seishi, Sugiura, Tetsuro, Hatada, Kengo, Tsuka, Yoshiaki, Umemura, Shigeo, Fujikawa, Yusuke, Baden, Masato, Iwasaka, Toshiji
Publikováno v:
Nuclear Medicine Communications; Oct2009, Vol. 30 Issue 10, p789-796, 8p